Cholecystitis. Calculus of gallbladder with acute cholecystitis
Conditions
Interventions
Intervention 1: Intervention group: Intervention group 1: The group receiving ondansetron (manufactured by Obidi Pharmaceutical Company - Iran) at a dose of 4 mg, administered intravenously once. Inte
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Having informed consent to participate in the study ASA class I or II
Exclusion criteria
Exclusion criteria: Steroid drug use within the past year Addiction Cancer History of chronic kidney disease Diabetes Pregnancy and breastfeeding Allergy to ondansetron and corticosteroid, Contraindications to corticosteroid use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Pain levels will be assessed by the study administrator immediately after transfer to recovery, 2, 4, and 24 hours after surgery. Method of measurement: Using of Visual Analogue Scale.;Nausea and vomiting. Timepoint: The amount of nausea and vomiting and its severity will be assessed by the study administrator immediately after transfer to recovery, 2, 4, and 24 hours after surgery. Method of measurement: Using the Rhodes Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahdi Khodadadi
Birjand University of Medical Sciences
Outcome results
None listed